Heart 1998;79:248-252 ( March )

Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies

J W G Yarnell,^a C C Patterson,^a D Bainton,^c P M Sweetnam^b

^a Epidemiology and Public Health, Queen's University, Belfast, UK, ^b MRC Epidemiology Unit, Cardiff, UK, ^c Gwent Health Authority, Pontypool, UK

Correspondence to: Dr Yarnell, Department of Epidemiology and Public Health, Mullhouse Building, Institute of Clinical Science, Grosvenor Road, Belfast B12 6BJ, UK.

Accepted for publication 12 November 1997

ObjectiveTo examine the clinical and epidemiological utility of the concepts of metabolic syndrome and insulin resistance syndrome in two prospective cohort studies of white men.
MethodsMen aged 45-63 years were screened for evidence of ischaemic heart disease (IHD) between 1979 and 1982 and followed up at regular intervals thereafter. Non-fatal coronary events were validated from hospital records and fatal coronary events from death certificates.
ResultsAnalysis of serum insulin concentrations in non-diabetic individuals measured at entry to the study showed no independent contribution to the prediction of subsequent IHD at 10 year follow up. Blood glucose concentrations, however, showed a small independent contribution in the combined cohort in the upper fifth of the distribution. Three different models of metabolic syndrome among non-diabetic individuals were defined based on tertiles, medians, and clusters. The predictive value of each model was assessed using logistic regression before and after adjustment for conventional and metabolic risk factors. After adjustment the odds were non-significant and close to unity.
ConclusionsThis study did not detect any complex relation among the five variables defining metabolic syndrome; the excess risk seems to be no greater than can be explained by individual effects of the defining variables in a multiple logistic model.

Keywords: metabolic syndrome;  insulin resistance;  screening;  ischaemic heart disease;  epidemiology

---

© 1998 by Heart
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Elwood, P. C, Pickering, J. E, Fehily, A. M (2007). Milk and dairy consumption, diabetes and the metabolic syndrome: the Caerphilly prospective study. J. Epidemiol. Community Health 61: 695-698 [Abstract] [Full Text]  
• Kahn, R. (2007). Metabolic Syndrome: Is It a Syndrome? Does It Matter?. Circulation 115: 1806-1811 [Full Text]  
• Iribarren, C., Go, A. S., Husson, G., Sidney, S., Fair, J. M., Quertermous, T., Hlatky, M. A., Fortmann, S. P. (2006). Metabolic Syndrome and Early-Onset Coronary Artery Disease: Is the Whole Greater Than Its Parts?. J Am Coll Cardiol 48: 1800-1807 [Abstract] [Full Text]  
• Kahn, R. (2006). The Metabolic Syndrome (Emperor) Wears No Clothes. Diabetes Care 29: 1693-1696 [Full Text]  
• Kohli, P., Greenland, P. (2006). Role of the Metabolic Syndrome in Risk Assessment for Coronary Heart Disease. JAMA 295: 819-821 [Full Text]  
• Eberly, L. E., Prineas, R., Cohen, J. D., Vazquez, G., Zhi, X., Neaton, J. D., Kuller, L. H., for the Multiple Risk Factor Intervention Trial Re, (2006). Metabolic Syndrome: Risk factor distribution and 18-year mortality in the Multiple Risk Factor Intervention Trial. Diabetes Care 29: 123-130 [Abstract] [Full Text]  
• Kahn, R., Buse, J., Ferrannini, E., Stern, M. (2005). The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28: 2289-2304 [Abstract] [Full Text]  
• Ebrahim, S., Smith, G. D., May, M., Yarnell, J. (2003). Shaving, Coronary Heart Disease, and Stroke: The Caerphilly Study. Am J Epidemiol 157: 234-238 [Abstract] [Full Text]  
• Davey Smith, G, Greenwood, R, Gunnell, D, Sweetnam, P, Yarnell, J, Elwood, P (2001). Leg length, insulin resistance, and coronary heart disease risk: The Caerphilly Study. J. Epidemiol. Community Health 55: 867-872 [Abstract] [Full Text]  
• Yarnell, J.W.G., Patterson, C. C., Sweetnam, P. M., Thomas, H. F., Bainton, D., Elwood, P. C., Bolton, C. H., Miller, N. E. (2001). Do Total and High Density Lipoprotein Cholesterol and Triglycerides Act Independently in the Prediction of Ischemic Heart Disease?: Ten-Year Follow-Up of Caerphilly and Speedwell Cohorts. Arterioscler. Thromb. Vasc. Bio. 21: 1340-1345 [Abstract] [Full Text]  
• Yarnell, J. W G, Patterson, C. C, Thomas, H. F, Sweetnam, P. M (2000). Comparison of weight in middle age, weight at 18 years, and weight change between, in predicting subsequent 14 year mortality and coronary events: Caerphilly Prospective Study. J. Epidemiol. Community Health 54: 344-348 [Abstract] [Full Text]  
• Pyorala, M., Miettinen, H., Halonen, P., Laakso, M., Pyorala, K. (2000). Insulin Resistance Syndrome Predicts the Risk of Coronary Heart Disease and Stroke in Healthy Middle-Aged Men : The 22-Year Follow-Up Results of the Helsinki Policemen Study. Arterioscler. Thromb. Vasc. Bio. 20: 538-544 [Abstract] [Full Text]  
• Yarnell, J.W.G., Patterson, C.C., Thomas, H.F., Sweetnam, P.M. (1999). Fasting plasma glucose and subsequent macrovascular disease after 10 years follow-up: a collaborative study on two populations. QJM 92: 207-210 [Abstract] [Full Text]